The FDA just approved the first direct competitor to a billion-dollar cancer drug (ROG.VX, AMGN)

REUTERS/Karoly Arvai The FDA just approved a version of Avastin, a blockbuster chemotherapy made by Genentech that brought in $ 6.7 billion in sales in 2016.  The newly approved drug, made by Amgen, will go by the marketed name Mvasi. It’s a type of medication called a “biosimilar.”  Biosimilars are a bit more complicated than your average […]